News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Mechanism of cell cycle regulation molecules revealed
Key insights into the workings of regulatory molecules that are implicated in the development of solid tumours have been revealed by scientists at The Institute of Cancer Research, London.
New cancer drug shows impressive results in patients with BRCA mutations
A new potential cancer drug designed to fight tumours with faulty BRCA genes has generated impressive responses in an early-stage clinical trial.
ICR researchers present at global cancer conference
Researchers from the ICR will be presenting their findings at the 2013 American Society of Clinical Oncology Annual Meeting, which opens today in Chicago.
Flower shape and new treatments for myeloma
ICR scientists find a genetic process that determines a flower's shape could also underlie the development of blood cancer.
A new model for genetic testing in cancer patients
An ICR research programme that will lay the foundations for anyone with cancer to have access to genetic testing has been launched with £2.7 million funding from the Wellcome Trust.
High-tech scans monitor activity of new drug treatments
Monitoring lactate within tumours using high-tech scans could tell doctors whether or not cancer drugs are working, new research reveals.
Statement about BRCA genetic research and testing
Statement from the ICR about BRCA genetic research and testing, in the light of the announcement by Angelina Jolie that she has had a double mastectomy to reduce her BRCA1-associated risk of developing breast cancer.
Large study identifies nine new genomic regions linked to testicular cancer
A study from the ICR involving over 2,000 men has identified nine new regions of the genome associated with testicular cancer.
Timing of Hodgkin lymphoma radiotherapy to women’s first period critical for breast cancer risk
ICR scientists find radiotherapy near a woman's first period increases breast cancer risk, but pregnancy doesn't increase danger.
Mapping cancer’s networks
Building up a London Underground-style map of signalling pathways is pinpointing cancer’s weak points
Researchers identify indicator for drug-resistant head and neck cancers
Scientists have uncovered a secret to why many tumours develop resistance to a class of targeted drug treatments.
New DNA blood test could increase access to Herceptin
ICR scientists believe a new blood test for women with breast cancer could identify more women who will benefit from the targeted treatment Herceptin without the need for uncomfortable biopsies.
